Tech Company Inital Public Offerings
Day One Biopharmaceuticals IPO
Day One Biopharmaceuticals was acquired by . Shares were listed on 5/27/2021.
Transaction Overview
Company Name
Announced On
5/27/2021
Transaction Type
IPO
Amount
$134,400,000
Proceeds Purpose
Use of proceeds for the Day One Biopharmaceuticals IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
395 Oyster Point Blvd. 217
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Day One takes a different approach, encompassing patients of all ages. Inspired by a call to action from the pediatric oncology community, Day One listens to, and acts in service of the needs of patients, their families, and their treating oncologists.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Julie Grant
Chief Executive Officer
Jeremy Bender
Chief Financial Officer
Sharon Tetlow
Chief Medical Officer
Samuel Blackman
Chief Technical Officer
Michael Preigh
Vice President
Jeannie Hou
VP - Bus. Development
Lisa Bowers
VP - Bus. Development
Davy Chiodin
VP - Bus. Development
Michael Cox
VP - Bus. Development
Lazar Dimitrov
VP - Operations
Isagani Cornelio
Browse more venture capital transactions:
Prev: 5/27/2021: Hello Heart venture capital transaction
Next: 5/27/2021: Torus Biosystems venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs